showed a trendp = 0.087
Spikevax recipients showed a trend towards a higher likelihood of reporting symptoms compared to Comirnaty recipients (OR 1.64 (0.94, 2.94), p = 0.087).
Spikevax recipients showed a trend towards a higher likelihood of reporting symptoms compared to Comirnaty recipients (OR 1.64 (0.94, 2.94), p = 0.087).